57 related articles for article (PubMed ID: 24479884)
1. Abnormal liver function test in hydatidiform moles: a retrospective study comparing the hyperthyroid state and the euthyroid state.
Kucukoglu ME; Dulger AC; Aslan M; Olmez S; Guler A; Aldemir MN; Ebinc S; Karadas S; Demirkıran D
Gynecol Endocrinol; 2014 Apr; 30(4):287-9. PubMed ID: 24479884
[TBL] [Abstract][Full Text] [Related]
2. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function among women with gestational trophoblastic diseases. A cross-sectional study.
Düğeroğlu H; Özgenoğlu M
Sao Paulo Med J; 2019 Aug; 137(3):278-283. PubMed ID: 31411244
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole.
Amir SM; Osathanondh R; Berkowitz RS; Goldstein DP
Am J Obstet Gynecol; 1984 Nov; 150(6):723-8. PubMed ID: 6496594
[TBL] [Abstract][Full Text] [Related]
5. The application of an immunoradiometric assay of plasma thyrotropin (TSH-IRMA) in molar pregnancy.
Berghout A; Endert E; Wiersinga WM; Touber JL
J Endocrinol Invest; 1988 Jan; 11(1):15-9. PubMed ID: 3361074
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
Ngowngarmratana S; Sunthornthepvarakul T; Kanchanawat S
J Med Assoc Thai; 1997 Nov; 80(11):693-9. PubMed ID: 9385765
[TBL] [Abstract][Full Text] [Related]
7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between malignant transformation and fertilization types of hydatidiform moles].
Zhang XW; Zhu HB; Gao YQ; Wu SY; Gao RL; Han JS; Wang XY; Wang R; Guo HY; Zhao YY; Zhao WQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):215-7. PubMed ID: 15100747
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of hydatidiform moles.
Fox H
Gen Diagn Pathol; 1997 Nov; 143(2-3):117-25. PubMed ID: 9443569
[TBL] [Abstract][Full Text] [Related]
10. [Clinic characteristics of patients with trophoblastic gestational disease complicate with hypertension].
Tovar-Rodríguez JM; Medel-Lagunes Idel C; Acosta-Altamirano G; Vargas-Hernández VM
Ginecol Obstet Mex; 2013 Oct; 81(10):578-86. PubMed ID: 24483040
[TBL] [Abstract][Full Text] [Related]
11. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid.
Hershman JM
Best Pract Res Clin Endocrinol Metab; 2004 Jun; 18(2):249-65. PubMed ID: 15157839
[TBL] [Abstract][Full Text] [Related]
12. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
Ho PC; Wong LC; Ma HK
Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
[TBL] [Abstract][Full Text] [Related]
13. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
14. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
Kamariah K; Satgunasingam N; Nasri NM; Ng KY
Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
[TBL] [Abstract][Full Text] [Related]
15. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
16. The natural history of theca lutein cysts.
Montz FJ; Schlaerth JB; Morrow CP
Obstet Gynecol; 1988 Aug; 72(2):247-51. PubMed ID: 2455880
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles.
Soni S; Rath G; Deval R; Salhan S; Mishra AK; Saxena S
Am J Reprod Immunol; 2011 Sep; 66(3):230-6. PubMed ID: 21385271
[TBL] [Abstract][Full Text] [Related]
18. Transient hyperthyroidism in an adolescent with hydatidiform mole.
Misra M; Levitsky LL; Lee MM
J Pediatr; 2002 Mar; 140(3):362-6. PubMed ID: 11953736
[No Abstract] [Full Text] [Related]
19. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
